2+ week, 6+ day ago   (970+ words) Vendor oversight cannot be treated only as relationship management or periodic status review: It has to function as part of a quality system. Organizations can strengthen that capability by moving beyond status-based oversight and focusing on specific controls to see…...

2+ day, 19+ hour ago   (1531+ words) Leadership excellence could improve significantly with support from AI feedback systems. Herein, the writers imagine how the next generation of high-impact leaders will learn to partner with wearable AI systems to facilitate communication and decision-making in biomanufacturing environments. Conceptual snapshot…...

3+ week, 4+ day ago   (481+ words) Although cell and gene therapies are gaining traction commercially, the distance between patients and specialized collection centers threatens to exacerbate current problems with accessibility. The writers demonstrate how decentralized apheresis offers a practical path for addressing concerns with access and…...

1+ week, 3+ day ago   (1123+ words) The future of biopharmaceutical commercial analytics is not agentic AI versus humans, but governed collaboration between the two. Human-in-the-loop models provide a scalable path forward by combining the speed and breadth of automation with the judgment, accountability, and trust required…...

3+ day, 13+ hour ago   (552+ words) An executive from Thermo Fisher discusses how AI stands to transform the industry without compromising the need for human operators. Use cases for AI tools continue to evolve in biopharmaceutical development and manufacturing. The technology already has tremendous influence on…...

3+ week, 4+ day ago   (333+ words) The CEO called the achievement a “major milestone” for his company’s global manufacturing strategy. Contract development and manufacturing organization (CDMO) WuXi XDC announced the GMP release of its BCM3 dual-function production line for antibody intermediates and drug substances at its site…...